|
2'-deoxy-2'-fluoro-2'-C-methyluridine
|
(2'R)-2'-脱氧-2'-氟-2'-甲基脲苷
|
863329-66-2
|
|
Cytidine, N-benzoyl-2'-deoxy-2'-fluoro-2'-methyl-, 3',5'-dibenzoate,(2'R)-
|
(2'R)-N-苯甲酰基-2'-脱氧-2'-氟-2'-甲基胞苷 3',5'-二苯甲酸酯
|
817204-32-3
|
|
PSI 7977
|
索非布韦
|
1190307-88-0
|
|
Ledipasvir (acetone)
|
雷迪帕韦单丙酮溶剂化物
|
1441674-54-9
|
|
Velpatasvir
|
维帕他韦
|
1377049-84-7
|
|
Velpatasvir intermediate;tert-butyl(2S,4S)-2-[5-(2-{(2S,5S)-1-[N-(methoxycarbonyl)-L-valyl]-5-methylpyrrolidin-2-yl}-1,11-dihydroisochromeno[4′,3′:6,7]naphtho[1,2-d]imidazol-9-yl)-1H-imidazol-2-yl]-4-(methoxymethyl)pyrrolidine-1-carboxylate
|
2S,4S)-2-[5-[1,11-二氢-2-[(2S,5S)-1-[(2S)-2-[(甲氧羰基)氨基]-3-甲基-1-氧代丁基]-5-甲基-2-吡咯烷基][2]苯并吡喃并[4',3':6,7]萘并[1,2-D]咪唑-9-基]-1H-咪唑-2-基]-4-(甲氧基甲基)-1-吡咯烷羧酸叔丁酯;GS-5816 N-3中间体;叔丁基(2S,4S)-2-[5-(2-{(2S,5S)-1-[N-(甲氧基羰基)-L-缬氨酰]-5-甲基吡咯烷-2-基}-1,11-二氢异吡喃[4′,3′:6,7]萘并[1,2-D]咪唑-9-基)-1H-咪唑-2-基] -4-(甲氧基甲基)吡咯烷-1-羧酸
|
1378391-45-7
|
|
(5S)-N-(Methoxycarbonyl)-L-valyl-5-methyl-L-proline;(2S,5S)-1-((methoxycarbonyl)-L-valyl)-5-methylpyrrolidine-2-carboxylic acid;(2S,4S)-1-((R)-2-((methoxycarbonyl)amino)-2-phenylacetyl)-4-(methoxymethyl)pyrrolidine-2-carboxylicacid;(5S)-N-(Methoxycarbonyl)-L-valyl-5-methyl-L-proline;(2S,5S)-1-((S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-5-methylpyrrolidine-2-carboxylic acid
|
(5S)-N-(甲氧羰基)-L-缬氨酰-5-甲基-L-脯氨酸；VELPATASVIR 中间体;(5S)-N-(甲氧羰基)-L-缬氨酰-5-甲基-L-脯氨酸
|
1335316-40-9
|
|
Velpatasvir intermediate;VP N-3;
(2R,4R)-1-tert-butyl2-(2-(9-((2S,5S)-1-((S)-2-(methoxycarbonylamino)-3-methylbutanoyl)-5-methylpyrrolidine-2-carbonyloxy)-8-oxo-8,9,10,11-tetrahydro-5H-dibenzo[c,g]chromen-3-yl)-2-oxoethyl) 4-(methoxymethyl)pyrrolidine-1,2-dicarboxylate
|
维帕他韦中间体VP N-3;(2R,4R)-1-叔丁基2-(2-(9-((2S,5S)-1-((S)-2-(甲氧基羰基氨基)-3-甲基丁酰基)-5-甲基吡咯烷-2-羰氧基)-8-氧代-8,9,10,11-四氢-5H-二苯并[C,G]吡喃-3-基)2-氧代乙基)-4-(甲氧基甲基)吡咯烷-1,2-二羧酸
|
1378391-43-5
|
|
Velpatasvir intermediate;tert-butyl(2S,4S)-2-[5-(2-{(2S,5S)-1-[N-(methoxycarbonyl)-L-valyl]-5-methylpyrrolidin-2-yl}-1,4,5,11-tetrahydroisochromeno[4′,3′:6,7]naphtho[1,2-d]imidazol-9-yl)-1H-imidazol-2-yl]-4-(methoxymethyl)pyrrolidine-1-carboxylate
|
维帕他韦中间体；叔丁基 (2S,4S)-2-[5-(2-{(2S,5S)-1-[N-(甲氧基羰基)-L-缬氨酰]-5-甲基吡咯烷-2-基}-1,4,5,11-四氢异吡喃[4′,3′:6,7]萘并[1,2-D]咪唑-9-基)-1H-咪唑-2-基]-4-(甲氧基甲基)吡咯烷-1-羧酸
|
1378391-44-6
|
|
Chenodeoxycholic acid;URSODEOXYCHOLOCACID;3,7-dihydroxy-,(3-alpha,5-beta,7-alpha)-cholan-24-oicaci;3,7-dihydroxy-,(3alpha,5beta,7alpha)-cholan-24-oicaci;3,7-Dihydroxy-5-Cholanicacid;3-alpha,7-alpha-dihydroxy-5-beta-cholan-24-oicaci;3-alpha,7-alpha-dihydroxy-5-beta-cholan-24-oicacid;3-alpha,7-alpha-dihydroxycholanicacid;3-alpha,7-alpha-dihydroxycholansaeure
|
鹅去氧胆酸；鹅脱氧胆酸;脱氧鹅胆酸;脱氧脲苷;3alpha,7alpha-二羟基-5beta-胆烷酸;3α,7α-二羟基-5-β-胆烷酸;3α,7α-二羟基胆质酸;护肝素
|
474-25-9
|
|
GSK1349572sodiuMsalt;DOLUTEGRAVIRSODIUM;GSK1349572A;Dolutegravir sodiuM salt;Dolutegravir SodiuM ( API)
|
度鲁特韦钠盐；度鲁特韦钠
|
1051375-19-9
|
|
Dolutegravi;GSK1349572;(4R,12aS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide;S/GSK1349572(GSK1349572);Dolutegravir;GSK1349572(dolutegravir);S/GSK1349572;dolutegravir/GSK1349572/S-349572;Dolutegravir API
|
杜鲁特韦；(4R,12AS)-N-[(2,4-二氟苯基)甲基]-3,4,6,8,12,12A-六氢-7-羟基-4-甲基-6,8-二氧代-2H-吡啶并[1',2':4,5]吡嗪并[2,1-B][1,3]嗪-9-甲酰胺;度鲁特韦;德罗特韦;4R,12AS)-N-[(2,4-二氟苯基)甲基]-3,4,6,8,12,12A-六氢-7-羟基-4-甲基-6,8-二氧代-2H-吡啶并[1;DOLUTEGRAVIR 度鲁特韦;德罗特韦 GSK1349572;德罗特韦(GSK-1349572,DTG);
|
1051375-16-6
|
|
(2S,4S)-1-(tert-butoxycarbonyl)-4-(MethoxyMethyl)pyrrolidine-2-carboxylic acid;(2S,4S)-1-(tert-butoxycarbonyl)-4-(MethoxyMethyl)pyrrolidine-2-carboxylic acid;(2S,4S)-4-(Methoxymethyl)-1,2-pyrrolidinedicarboxylicacid1-(1,1-dimethylethyl)ester;GS-5816interMediate;3-(2-bromoacetyl)-10,11-dihydro-5H-dibenzo[c,g]chromen-8(9H)-one
|
(2S,4S)-1-(叔丁氧羰基)-4-(甲氧甲基)吡咯啉-2-羧酸；(2S,4S)-1-(叔丁氧羰基)-4-(甲氧甲基)吡咯啉-2-羧酸;(2S,4S)-4-(甲氧基甲基)-1,2-吡咯烷二甲酸 1-叔丁基酯;GS-5816中间体;5816中间体,SM2
|
1378388-16-9
|
|
9-Bromo-3-(2-Bromo Acetyl)-10,11-Dihydro-5H-dibenzo(c,g) Chromen-8(9H)-one
|
9-溴-3-(2-溴乙酰基)-10,11-二氢-5H-二苯并(C,G) CHROMEN-8(9H)-酮
|
1438383-89-1
|
|
(1R,3S,4S)-N-Boc-2-azabicyclo[2.2.1]heptane-3-carboxylic acid
|
(1R,3S,4S)-N-叔丁氧羰基-2-氮杂双环[2.2.1]庚烷-3-羧酸
|
291775-59-2
|
|
(1R,3S,4S)-3-[6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzimidazol-2-yl]-2-azabicyclo[2.2.1]heptane-2-carboxylic acid 1,1-dimethylethyl ester
|
(1R,3S,4S)-3-[6-(4,4,5,5-四甲基-1,3,2-二氧杂环戊硼烷-2-基)-1H-苯并咪唑-2-基]-2-氮杂双环[2.2.1]庚烷-2-羧酸叔丁酯
|
1256387-87-7
|
|
Mirabegron;YM 178;Mirabegron;MIRABEQRON;Mirabegron, >=99%;Mirabegron(YM 178);Merariveron impurity B;N-(4-(2-(2-hydroxy-2-phenylethylamino)ethyl)phenyl)-2-(2-aminothiazol-4-yl)acetamide;2-AMino-N-[4-[2-[[(2R)-2-hydroxy-2-phenyl-ethyl]aMino]-ethyl]phenyl]-4-thiazoleacetaMide;4-Thiazoleacetamide, 2-amino-N-(4-(2-(((2R)-2-hydroxy-2-phenylethyl)amino)ethyl)phenyl)-;2-(2-aMino-1,3-thiazol-4-yl)-N-(4-{2-[(2-hydroxy-2-phenylethyl)aMino]ethyl}phenyl)acetaMide
|
米拉贝隆；米拉贝隆;米拉贝隆API;米拉贝隆杂质B;2-氨基-N-[4-[2-[[(2R)-2-羟基-2-苯基乙基]氨基]乙基]苯基]-4-噻唑乙酰胺;(R)-2-(2-氨基噻唑-4-基)-4'-[2-[(2-羟基-2-苯基乙基) 氨基]乙基]乙酸酰基苯胺
|
223673-61-8
|
|
N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid dimethyl ester hydrochloride;BMS790052;N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic aciddimethylesterhydrochloride;BMS-790052(dihydrochloride);BMS790052HCl;Daclatasvirdihydrochloride;DACLATASVIR(2HCl);Daclatasvir HCL
|
达卡他韦二盐酸盐；N,N'-[[1,1'-联苯]-4,4'-二基双[1H-咪唑-5,2-二基-(2S)-2,1-吡咯烷二基[(1S)-1-(1-甲基乙基)-2-氧代-2,1-乙烷二基]]]二氨基甲酸二甲酯二盐酸盐;吡咯烷二基[(1S)-1-(1-甲基乙基)-2-氧代-2,1-乙烷二基]]]二氨基甲酸二甲酯二盐酸盐;达卡他韦双盐酸盐;达卡他韦二盐酸盐;盐酸达卡他韦;达卡他韦,达卡他韦二盐酸盐;达卡他韦盐
|
1009119-65-6
|
|
1-(7-Bromo-9,9-difluoro-9H-fluoren-2-yl)-2-chloroethanone
|
1-(7-溴-9,9-二氟-9H-芴-2-基)-2-氯乙酮
|
1378387-81-5
|
|
(S)-5-(tert-Butoxycarbonyl)-5-azaspiro[2.4]heptane-6-carboxylic acid
|
(6S)-5-叔丁氧羰基-5-氮杂螺-[2.4]-庚烷-6-羧酸
|
129634-44-1
|
|
(1R,3S,4S)-3-(6-Bromo-1H-benzimidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylic acid 1,1-dimethylethyl ester
|
(1R,3S,4S)-3-(6-溴-1H-苯并咪唑-2-基)-2-氮杂双环[2.2.1]庚烷-2-羧酸叔丁酯
|
1256387-74-2
|
|
Daclatasvir;dimethyl(2S,2'S)-1,1'-((2S,2'S)-2,2'-(4,4'-(biphenyl-4,4'-diyl)bis(1H-imidazole-4,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate;diMethyl(2S,2'S)-1,1'-((2S,2'S)-2,2'-(4,4'-(biphenyl-4,4'-diyl);Daclatasvir;EBP883;N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acidC,C'-dimethylester;Daclatasvir/EBP883;daclatavir;BMS-790052(Daclatasvir)
|
达卡他韦；N,N'-[[1,1'-联苯]-4,4'-二基双[1H-咪唑-5,2-二基-(2S)-2,1-吡咯烷二基 [(1S)-1-(1-甲基乙基)-2-氧代-2,1-乙烷二基]]]双氨基甲酸 C,C'-二甲酯;DACLATASVIR (BMS-790052) N,N'-[[1,1'-联苯]-4,4'-二基双[1H-咪唑-5,2-二基-(2S)-2,1-吡咯烷二基 [(1S)-1-(1-甲基乙基)-2-氧代-2,1-乙烷二基]]]双氨基甲酸 C,C'-二甲酯;
|
1009119-64-5
|
|
(6S)-6-[5-(7-Bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]heptane-5-carboxylic acid 1,1-dimethylethyl ester
|
(6S)-5-叔丁氧羰基-6-(5-(7-溴-9,9-二氟-9H-芴-2-基)-1H-咪唑-2-基)-5-氮杂螺-[2.4]-庚烷
|
1441670-89-8
|
|
Obeticholic Acid;6-Ethylchenodeoxycholicacid;6alpha-Ethyl-chenodeoxycholicacid;6-Ecdca;6-Ethyl-cdca;C15636;6-Ethylchenodeoxycholicacid(ObeticholicAcid);Obeticholic Acid;(3α,5β,6α,7α)-6-ethyl-3,7-dihydroxy-cholan-24-oic acid
|
奥贝胆酸；6-乙基鹅去氧胆酸;奥贝胆酸;奥贝胆酸 (6-乙基鹅去氧胆酸);奥贝胆酸 459789-99-2 ECDC
|
459789-99-2
|
|
N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester
|
N-[(S)-(2,3,4,5,6-五氟苯氧基)苯氧基磷酰基]-L-丙氨酸异丙酯
|
1334513-02-8
|